ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Revvity Inc

Revvity Inc (RVTY)

110.505
2.35
(2.18%)
At close: July 22 4:00PM
110.505
0.00
( 0.00% )
After Hours: 3:50PM

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Key stats and details

Current Price
110.505
Bid
-
Ask
-
Volume
276,426
108.03 Day's Range 110.52
79.50 52 Week Range 132.00
Market Cap
Previous Close
108.15
Open
109.01
Last Trade
95829
@
110.69
Last Trade Time
Financial Volume
$ 30,128,322
VWAP
108.9924
Average Volume (3m)
888,796
Shares Outstanding
123,392,991
Dividend Yield
0.25%
PE Ratio
19.71
Earnings Per Share (EPS)
5.62
Revenue
2.75B
Net Profit
693.09M

About Revvity Inc

PerkinElmer provides instruments, tests, services, and software solutions to the pharmaceutical, biomedical, chemical, environmental, and general industrial markets. The company operates in two segments: diagnostics, which includes immunodiagnostics, reproductive health, and applied genomics, and di... PerkinElmer provides instruments, tests, services, and software solutions to the pharmaceutical, biomedical, chemical, environmental, and general industrial markets. The company operates in two segments: diagnostics, which includes immunodiagnostics, reproductive health, and applied genomics, and discovery and analytical solutions, composed of life science, industrial, environmental, and food applications. PerkinElmer offers products and services ranging from genetic screening and environmental analytical tools to informatics and enterprise software. Show more

Sector
Lab Analytical Instruments
Industry
Engineering Services
Headquarters
Waltham, Massachusetts, USA
Founded
2001
Revvity Inc is listed in the Lab Analytical Instruments sector of the New York Stock Exchange with ticker RVTY. The last closing price for Revvity was $108.15. Over the last year, Revvity shares have traded in a share price range of $ 79.50 to $ 132.00.

Revvity currently has 123,392,991 shares outstanding. The market capitalization of Revvity is $13.34 billion. Revvity has a price to earnings ratio (PE ratio) of 19.71.

RVTY Latest News

Revvity To Hold Earnings Call on Monday, July 29, 2024

Revvity, Inc. (NYSE: RVTY), today announced that it will release its second quarter 2024 financial results prior to market open on Monday, July 29, 2024. The Company will host a conference call...

Bionano Announces Software Marketing Agreement with Revvity for Newborn Sequencing Research

Bionano has entered into a software marketing agreement with Revvity, Inc. (Revvity) under which Revvity will market and commercialize Bionano’s VIA™ software to Revvity’s next generation...

Revvity to Present at Goldman Sachs Global Healthcare Conference

Revvity, Inc. (NYSE: RVTY) will present at the 45th Annual Goldman Sachs Global Healthcare Conference on Monday, June 10, 2024 at 8:00 a.m. ET in Miami, FL. Prahlad Singh, president and chief...

Revvity Announces Financial Results for the First Quarter of 2024

Revenue of $650 million; (4)% reported growth; (3)% organic growth First quarter GAAP EPS of $0.21; Adjusted EPS from continuing operations of $0.98 Reaffirms full year 2024 organic growth and...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
11.2151.11172110898109.29114.11106.92971788110.83862412CS
42.0651.90427886389108.44114.11101.295858915107.12161692CS
127.0756.84037513294103.43114.335100.34888796107.92707696CS
262.7152.51878652936107.79114.33597.315880985106.62718615CS
52-20.16-15.4287682241130.66513279.5841194105.35078473CS
156-5.835-5.01547189273116.3413279.5830446107.07781661CS
260-5.835-5.01547189273116.3413279.5830446107.07781661CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
MIRAMIRA Pharmaceuticals Inc
$ 5.01
(627.35%)
158.07M
CMAXCareMax Inc
$ 5.19
(228.48%)
102.64M
NUKKNukkleus Inc
$ 0.499
(55.94%)
26.19M
SNOASonoma Pharmaceuticals Inc
$ 0.423
(37.34%)
4.87M
ONDSOndas Holdings Inc
$ 1.1297
(34.06%)
2.19M
LGCBLinkage Global Inc
$ 3.6601
(-29.82%)
168k
CGBSCrown LNG Holdings Ltd
$ 0.9997
(-29.10%)
3.38M
SPECSpectaire Holdings Inc
$ 0.3962
(-24.53%)
1.87M
GSUNGolden Sun Health Technology Group Ltd
$ 5.13
(-23.66%)
158.58k
PSNLPersonalis Inc
$ 2.9808
(-22.58%)
3.1M
NVDANVIDIA Corporation
$ 123.54
(4.76%)
238.89M
SQQQProShares UltraPro Short QQQ
$ 8.09
(-4.37%)
183.49M
MIRAMIRA Pharmaceuticals Inc
$ 5.01
(627.35%)
158.07M
SERVServe Robotics Inc
$ 8.73
(15.63%)
151.5M
NCPLNetcapital Inc
$ 0.1118
(7.50%)
124.27M

Discussion

View Full Feed
patrik patrik 3 minutes ago
W2R,
But there are some here expecting any day kaboom! I’m looking
at end of year or possibility early 2025
Patrik
KBLB
Stinger2014 Stinger2014 5 minutes ago
The good news, the MC can’t get much lower. I still believe the RS is already baked in.
CGAC
DesertDrifter DesertDrifter 5 minutes ago
Yep. I was just thinking out loud. Still not a lot of official stuff coming out about the Ear of Trump episode. No legit medical release that mentions any stitches, grafts, etc. the photos of him golfing without bandage the day after with no visible wounds seems still curious.
fuagf fuagf 5 minutes ago
Yep. It's a must do now after you've thrown that gauntlet down. https://www.democraticunderground.com/emoticons/toast.gif
LCJR LCJR 5 minutes ago
Volume seems correct. Not sure about the individual trades though.

LCJR
AAGC
somberfox somberfox 6 minutes ago
All of that experience, and here we are at near trip 0s with millions in dilution, a deal with your biggest partner gone in the wind and a month behind on an audit of nothing.

Hey, we're getting a watch though.
RONN
SSKILLZ1 SSKILLZ1 6 minutes ago
SSKMP Managed Index (As Of 7/22/24)

Daily Performance
-0.08%

YTD Performance
+5.20%

Overall Performance
+494.90% (Including Options Trading +358.88%)
ExtremelyBullishZig ExtremelyBullishZig 6 minutes ago
Cool! So he can bring the drug to market then? Or is he just better at making the science work...I am trying to figure this one out. Steady told us that no one's opinion matters...
AVXL
ddls ddls 7 minutes ago
Yes, let's get this-junk going, for the note-holders.

https://www.otcmarkets.com/otcapi/company/financial-report/397773/content
BIEL
janice shell janice shell 8 minutes ago
I've never even thought of making my own ketchup. And I've been eating Heinz all my life. I'm still alive. I don't use all that much of it, though. I use much more mayo.
Ashley250nelson Ashley250nelson 8 minutes ago
Trials starting next week!lfgo Jim saved us
GSTC
GMH* GMH* 8 minutes ago
The company themselves said that the dropout rate will decline over time, so I am going from that, but they also said it was in-line with trials. Also, note that the 5% drop was, I assume, from patient health decline. There was also a statement in the same article that the manufacturing success ra
IOVA
bigstocksnbonds bigstocksnbonds 8 minutes ago
YES SIR!!!!!
MasterBlastr MasterBlastr 9 minutes ago
Have to take advantage of the rules of the game, to make it fair.
bigstocksnbonds bigstocksnbonds 9 minutes ago
Awesome yes!!!!!
Real McCoy Real McCoy 9 minutes ago
If you are going to start the cycle by saying that some folks here are cruelly committed to not allowing complete lies and fantasies to sit unrefuted, I will gladly complete the cycle by noting you are also guilty of an equal committment to fight for the right to say you believe said lies and fantas
Scott 75 Scott 75 9 minutes ago
Hopefully not on a cold slab somewhere.
UATG
janice shell janice shell 10 minutes ago
Bobo is just so breathtakingly stupid.
BADALI BADALI 10 minutes ago
I am watching this week and will add if goes Lower.
HIRU
_-Abe-_ _-Abe-_ 10 minutes ago
Just remember. This company has a pile of back orders to fill and are now able to begin that process. I’m looking forward to Q4 numbers.
EOSE
Genz2 Genz2 11 minutes ago
https://www.theregister.com/AMP/2024/07/22/windows_crowdstrike_kernel_eu/

Why is Microsoft blaming the EU when it is apparent that they didn’t allow Wave on Windows 10 and 11? I think they allowed Crowdstrike on their platform because they knew that Clownstrike was inferior to Window
moosedogger moosedogger 11 minutes ago
"I won't sell for less than "60.00"

Prove that you really missed me! I think you are not only FOS but also suffer from excrement of the 11th magnitude clogging what used to be your brain.

You might be the saddest and mentally sickest creature on the iHub boards.
AUPH
irishintelligence irishintelligence 11 minutes ago
Who knows - it obviously does not matter. Nothing is stopping him from continuing to develop property.


http://cdn.ceo.ca.s3-us-west-2.amazonaws.com/1dr223l-Anatomy%20of%20a%20Basher%20-%20Do%20and%20Don%27t.pdf

“Use 10% fact and 90% suggestion”

Fa
SPZI

Your Recent History

Delayed Upgrade Clock